Exicure (XCUR) Institutional Ownership $5.14 +0.19 (+3.84%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$5.30 +0.17 (+3.21%) As of 08:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Exicure (NASDAQ:XCUR)CurrentInstitutional OwnershipPercentage42.82%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$3.25MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$926.57K Get XCUR Insider Trade Alerts Want to know when executives and insiders are buying or selling Exicure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data XCUR Institutional Buying and Selling by Quarter Exicure Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Carlyle Group Inc.281,636$3.85M0.9%+400.0%10.791% 2/12/2025Geode Capital Management LLC12,645$173K0.0%N/A0.484% 11/12/2024Northwestern University10,430$36K0.0%-80.0%0.603% 11/8/2024Carlyle Group Inc.56,328$195K0.0%-80.0%3.256% 8/10/2023Carlson Capital L P125,000$164K0.0%-33.9%1.445% 5/5/2023Carlyle Group Inc.281,636$242K0.0%N/A3.365% 2/14/2023Susquehanna International Group LLP42,816$49K0.0%N/A0.863% 11/15/2022Carlson Capital L P190,000$298K0.0%+90.0%3.831% 11/10/2022Sigma Planning Corp21,807$34K0.0%N/A0.439% 7/13/2022Northwestern University52,146$113K0.1%-96.7%1.275% Get the Latest News and Ratings for XCUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter. 4/20/2022Sigma Planning Corp519,500$104K0.0%+206.1%0.423% 3/25/2022Privium Fund Management UK Ltd1,695,028$332K0.1%N/A1.924% 2/4/2022Salzhauer Michael166,600$34K0.0%-31.0%0.189% 2/2/2022Sigma Planning Corp169,700$34K0.0%+898.2%0.193% 11/15/2021HighTower Advisors LLC73,867$88K0.0%+48.0%0.084% 11/12/2021Prosight Management LP5,125,000$6.15M3.4%+42.4%5.817% 11/9/2021BlackRock Inc.511,345$614K0.0%+37.0%0.580% 11/2/2021Raymond James & Associates75,500$91K0.0%+20.8%0.086% 10/27/2021Tybourne Capital Management HK Ltd.7,325,000$8.79M0.2%-0.2%8.314% 8/17/2021Millennium Management LLC942,473$1.41M0.0%+1,592.4%1.071% 8/17/2021Boothbay Fund Management LLC24,835$37K0.0%N/A0.028% 8/16/2021LMR Partners LLP18,401$28K0.0%N/A0.021% 8/16/2021New York Life Investments Alternatives273,869$411K0.3%+1,189.7%0.311% 8/16/2021Charles Schwab Investment Management Inc.35,031$53K0.0%-78.8%0.040% 8/16/2021State Street Corp116,209$174K0.0%-88.6%0.132% 8/16/2021Tibra Equities Europe Ltd177,400$266K0.1%N/A0.202% 8/16/2021Goldman Sachs Group Inc.75,342$113K0.0%+22.8%0.086% 8/13/2021Renaissance Technologies LLC171,720$258K0.0%+25.7%0.195% 8/13/2021Northern Trust Corp139,938$210K0.0%-78.6%0.159% 8/13/2021Geode Capital Management LLC763,312$1.14M0.0%-34.4%0.867% 8/13/2021Vanguard Group Inc.2,784,620$4.18M0.0%-9.3%3.165% 8/12/2021Dimensional Fund Advisors LP248,274$372K0.0%+28.9%0.282% 8/12/2021SG Americas Securities LLC177,760$267K0.0%N/A0.202% 8/12/2021JPMorgan Chase & Co.140,260$210K0.0%-42.6%0.159% 8/11/2021Bank of New York Mellon Corp46,445$70K0.0%-73.5%0.053% 8/11/2021Susquehanna International Group LLP32,551$49K0.0%N/A0.037% (Data available from 1/1/2016 forward) XCUR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XCUR shares? During the previous two years, the following institutional investors and hedge funds held shares of Exicure shares: Carlyle Group Inc. ($3.85M), and Geode Capital Management LLC ($173K), Northwestern University ($36K).Learn more on Exicure's institutional investors. What percentage of Exicure's stock is owned by institutional investors? 42.82% of Exicure's stock is owned by institutional investors. Learn more on XCUR's institutional investor holdings. Which institutional investors have been buying Exicure's stock? The following institutional investors have purchased Exicure's stock in the last 24 months: Carlyle Group Inc. ($225.31K), and Geode Capital Management LLC ($12.65K). How much institutional buying is happening at Exicure? Institutional investors have bought a total of 237,953 shares in the last 24 months. This purchase volume represents approximately $3.25M in transactions. Which of Exicure's major shareholders have been selling company stock? The following institutional investors have sold Exicure stock in the last 24 months: Carlyle Group Inc. ($225.31K), and Northwestern University ($41.72K). How much institutional selling is happening at Exicure? Institutional investors have sold a total of 267,023 shares in the last 24 months. This volume of shares sold represents approximately $926.57K in transactions. Related Companies Atara Biotherapeutics Major Shareholders MacroGenics Major Shareholders Coya Therapeutics Major Shareholders Biomea Fusion Major Shareholders HilleVax Major Shareholders MEI Pharma Major Shareholders Context Therapeutics Major Shareholders Adverum Biotechnologies Major Shareholders ALX Oncology Major Shareholders Oramed Pharmaceuticals Major Shareholders This page (NASDAQ:XCUR) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
